Loading...
PLBL is not a good buy right now. There are no proprietary buy signals, momentum is weakening (bearish MACD), and the latest 2025/Q1 fundamentals show sharp deterioration in earnings (net income and EPS down significantly YoY) with no obvious near-term catalyst. For an impatient buyer looking to enter immediately, the risk/reward is unfavorable at 9.93 with overhead resistance near the pivot (10.24) and R1 (~11.00).
Trend/Momentum: Bearish bias. MACD histogram is -0.0793 (below 0) and negatively expanding, indicating downside momentum is strengthening. RSI(6) at 42.5 is neutral but leaning weak (not oversold), so there isn’t a clear rebound signal yet. Moving averages are converging, suggesting consolidation rather than a confirmed uptrend. Key levels: Price (~9.93) is below the pivot (10.236), which is a near-term bearish setup unless it reclaims and holds above it. Support levels: S1 9.475 then S2 9.006. Resistance: pivot 10.236, then R1 10.996 and R2 11.465. Pattern-based projection: Similar-pattern stats imply a modest expected move (+0.26% next day/week) but a more meaningful +6.36% over the next month; however, with current bearish momentum and no catalysts, that upside is less reliable.
Intellectia Proprietary Trading Signals
and reclaims the pivot (10.236), opening room toward R1 (10.996).
shows significant YoY deterioration in profitability (net income and EPS sharply down).
2025/Q1: Revenue reported as 0 (0.00% YoY) and gross margin reported as 0 (0.00% YoY), offering no visible top-line traction in this snapshot. Net income fell to 226,423 (down -335.72% YoY) and EPS fell to 0.02 (down -300.00% YoY). Overall, the quarter reflects weakening earnings power rather than improving growth trends.
No analyst rating or price target change data was provided. Wall Street pro/con view cannot be reliably summarized from the given dataset.
